Trial Profile
Phase IV Study of DCE-MRI Using Dotarem in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 12 Aug 2019
Price :
$35
*
At a glance
- Drugs Gadoterate-meglumine (Primary)
- Indications Liver cancer
- Focus Diagnostic use
- Acronyms DCE-MRI
- Sponsors Guerbet
- 24 Jun 2019 Status changed from active, no longer recruiting to discontinued.
- 05 Mar 2018 Planned End Date changed from 1 Oct 2017 to 1 Apr 2018.
- 23 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Oct 2017.